Synthetic Blood Fades Away Into History (SYBD, OXBO, NFLD)

July 1, 2008 · Filed Under General 

In 1999 there were high hopes for synthetic blood.  In 2009 there look to be almost zero options for synthetic blood.

This morning we have seen an announcement out of Synthetic Blood International, Inc.
(OTCBB:SYBD) saying that the new name for the company is Oxygen Biotherapeutics, Inc.  It will also have a new stock ticker of “OXBO” on the OTC-Bulletin Board.  The company’s chairman noted that it has several exciting bio-therapeutic applications for its Oxycyte(R), yet none of them is synthetic blood.

If you recall, the big hope was banking on a company called Northfield Labs Inc. (NASDAQ: NFLD).  Its PolyHeme® blood substitute was hoped for by many as the holy grail for blood substitutes in emergency applications.  It unfortunately failed miserably, although the company still does routine updates on progress there.  We noted that this one is for all practical purposes in a zombie status.

In 2019 we’ll be talking about fake blood.  Likely it will be from some other company that might not even exist today.  For now it seems D.O.A.

Jon Ogg
July 1, 2008


Comments are closed.

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed